相似文献
1
Long-acting thyroid stimulator and related factors.长效甲状腺刺激素及相关因素
Proc R Soc Med. 1975 Apr;68(4):252-3. doi: 10.1177/003591577506800429.
2
The immunologic basis of Graves's disease.格雷夫斯病的免疫学基础。
N Engl J Med. 1972 Aug 31;287(9):463-4. doi: 10.1056/NEJM197208312870910.
3
[Effect of iodinization on some properties of LATS and antithyroid antibodies].[碘化对长效甲状腺刺激素及抗甲状腺抗体某些特性的影响]
Folia Endocrinol. 1974 Feb;27(1):110-6.
4
[TSH-receptor-bound antithyroid antibody and the etiology of Basedow's disease].[促甲状腺激素受体结合型抗甲状腺抗体与突眼性甲状腺肿的病因]
Nihon Rinsho. 1983;41(4):801-7.
5
[Long acting thyroid stimulating immunoglobulin in pathogenesis of diffused thyrotoxicosis (author's transl)].长效甲状腺刺激免疫球蛋白在弥漫性甲状腺毒症发病机制中的作用（作者译）
Sheng Li Ke Xue Jin Zhan. 1981 Feb;12(2):119-25.
6
[Significance of long-acting thyroid stimulator. Reflections on the 1st series of results].[长效甲状腺刺激素的意义。对首批系列结果的思考]
Minerva Med. 1974 Mar 14;65(19):995-8.
7
[Autoimmunization symptoms in thyroid diseases].[甲状腺疾病中的自身免疫症状]
Pol Tyg Lek. 1978 Dec 25;33(52):2011-3.
8
Thyroid stimulating immunoglobulins. The Watson Smith lecture 1983.促甲状腺素受体抗体。1983年沃森·史密斯讲座
J R Coll Physicians Lond. 1984 Jul;18(3):155-60.
9
Serum long acting thyroid stimulator protector in pregnancy complicated by Graves' disease.妊娠合并格雷夫斯病时血清长效甲状腺刺激物保护剂
Br Med J (Clin Res Ed). 1983 Mar 19;286(6369):934-5. doi: 10.1136/bmj.286.6369.934.
10
Indirect immunofluorescence and generation of cyclic-AMP investigation with Graves' patients' sera.采用格雷夫斯病患者血清进行间接免疫荧光和环磷酸腺苷生成研究。
Acta Med Hung. 1986;43(3):275-81.
引用本文的文献
1
Thyroid autoantibodies in pregnancy: their role, regulation and clinical relevance.孕期甲状腺自身抗体：其作用、调节及临床意义。
J Thyroid Res. 2013;2013:182472. doi: 10.1155/2013/182472. Epub 2013 Apr 18.
2
TSH receptor autoantibodies.促甲状腺激素受体自身抗体。
Autoimmun Rev. 2009 Dec;9(2):113-6. doi: 10.1016/j.autrev.2009.03.012. Epub 2009 Mar 27.
3
Determination of thyroid stimulating immunoglobulins (TSI) during the course of Graves' disease. A reliable indicator for remission and persistence of this disease?格雷夫斯病病程中促甲状腺素受体抗体（TSI）的测定。这是该疾病缓解和持续存在的可靠指标吗？
J Endocrinol Invest. 1978 Apr;1(2):155-61. doi: 10.1007/BF03350364.
本文引用的文献
1
Effects of long-acting thyroid stimulator (LATS) and LATS protector on human thyroid adenyl cyclase activity.长效甲状腺刺激素（LATS）和LATS保护物对人甲状腺腺苷酸环化酶活性的影响。
Br Med J. 1973 Jul 14;3(5871):72-5. doi: 10.1136/bmj.3.5871.72.
2
Direct evidence for human thyroidal stimulation by LATS-protector.长效甲状腺刺激素保护物对人体甲状腺刺激的直接证据。
J Clin Endocrinol Metab. 1973 Mar;36(3):517-21. doi: 10.1210/jcem-36-3-517.
3
New in vitro tests to detect the thyroid stimulator in sera from hyperthyroid patients by measuring colloid droplet formation and cyclic AMP in human thyroid slices.通过测量人甲状腺切片中的胶体滴形成和环磷酸腺苷来检测甲状腺功能亢进患者血清中甲状腺刺激物的新型体外试验。
J Clin Endocrinol Metab. 1973 May;36(5):859-66. doi: 10.1210/jcem-36-5-859.
Zotero 插件